230
Participants
Start Date
October 29, 2020
Primary Completion Date
March 17, 2026
Study Completion Date
July 14, 2026
rezatapopt
First-in-class, oral, small molecule p53 reactivator selective for the TP53 Y220C mutation.
pembrolizumab
Participants receive pembrolizumab 200 mg by intravenous (IV) infusion over 30 minutes.
WITHDRAWN
New York University Perlmutter Cancer Center, New York
RECRUITING
Memorial Sloan Kettering, New York
WITHDRAWN
New York University - Long Island Hospital, Mineola
NOT_YET_RECRUITING
University of Pittsburgh Medical Center, Pittsburgh
NOT_YET_RECRUITING
WellSpan York Cancer Center, York
RECRUITING
Abramson Cancer Center of the University of Pennsylvania, Philadelphia
RECRUITING
Medical Oncology Hematology Consultants, Newark
RECRUITING
Virginia Cancer Specialists, Fairfax
RECRUITING
Duke University, Durham
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Medical University of South Carolina, Charleston
RECRUITING
CHU de Nîmes, Nîmes
NOT_YET_RECRUITING
Advent Health, Orlando
RECRUITING
University of Miami - Sylvester Comprehensive Cancer Center, Miami
RECRUITING
Florida Cancer Specialists South, Port Charlotte
RECRUITING
Sarah Cannon Research Institute, Nashville
WITHDRAWN
Vanderbilt University Medical Center - Ingram Cancer Center, Nashville
RECRUITING
The Cleveland Clinic Taussig Cancer Center, Cleveland
WITHDRAWN
Indiana University, Indianapolis
RECRUITING
Karmanos Cancer Institute, Detroit
RECRUITING
University of Wisconsin Carbone Cancer Center, Madison
RECRUITING
Institute Cancer De Lorraine, Vandœuvre-lès-Nancy
NOT_YET_RECRUITING
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
RECRUITING
University of Oklahoma, Oklahoma City
NOT_YET_RECRUITING
UTSW - Moody Outpatient Center - Parkland Health, Dallas
NOT_YET_RECRUITING
UT Southwest Simmons Cancer Center, Dallas
RECRUITING
The University of Texas MD Anderson Cancer Center, Houston
RECRUITING
New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
RECRUITING
New Experimental Therapeutics - NEXT Oncology, Austin
RECRUITING
IRCCS - lstituto Nazionale Tumori - Fondazione G. Pascale, Napoli
RECRUITING
Rocky Mountain Cancer Center, Denver
RECRUITING
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
RECRUITING
USC Norris Comprehensive Cancer Center, Los Angeles
WITHDRAWN
Hoag Cancer Center, Irvine
NOT_YET_RECRUITING
University of California Irvine Chao Family Comprehensive Cancer Center, Irvine
WITHDRAWN
University of San Francisco, San Francisco
RECRUITING
Oregon Health & Science University (OHSU), Portland
RECRUITING
University of Washington, Fred Hutchinson Cancer Center, Seattle
RECRUITING
National Cancer Center of Singapore, Singapore
RECRUITING
Yale Cancer Center, New Haven
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Dana Farber Cancer Institute, Boston
NOT_YET_RECRUITING
Swedish Medical Center, Seattle
RECRUITING
Chris O'Brien Lifehouse Hospital, Camperdown
RECRUITING
Mater Cancer Care Centre, South Brisbane
RECRUITING
Flinders Medical Center, Bedford Park
RECRUITING
Monash Medical Centre, Clayton
RECRUITING
Linear Clinical Research, Nedlands
RECRUITING
ICANS - Institut de cancérologie Strasbourg Europe, Strasbourg
RECRUITING
Institut Bergonie, Bordeaux
RECRUITING
Institut Claudius Regaud, Toulouse
RECRUITING
EDOG Institut de Cancerologie de l'Ouest, Saint-Herblain
RECRUITING
Centre Jean Perrin, Clermont-Ferrand
RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
Centre Léon Bérard Centre Régional de Lutte Contre Le Cancer, Lyon
RECRUITING
Nationale Centrum für Tumorerkrankungen (NCT) Heidelberg, Heidelberg
RECRUITING
Universitätsklinikum Augsburg, Augsburg
RECRUITING
Asklepios Klinik Altona, Hamburg
RECRUITING
Universitätsklinikum Frankfurt, Frankfurt am Main
RECRUITING
Universitätsklinikum Essen, Essen
RECRUITING
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome
RECRUITING
Istituti Fisioterapici Ospitalieri - Istituto Nazionale Tumori Regina Elena, Rome
RECRUITING
ASST Grande Ospedale Metropolitano Niguarda, Milan
RECRUITING
Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
RECRUITING
Istituto Europeo Di Oncologia, Milan
RECRUITING
Istituto Clinico Humanitas, Rozzano
RECRUITING
Fondazione del Piemonte per l'Oncologia (IRCCS), Candiolo
NOT_YET_RECRUITING
Humanitas San Pio X, Milan
RECRUITING
National University Hospital, Kent Ridge
RECRUITING
Asan Medical Center, Seoul
NOT_YET_RECRUITING
National Cancer Center, Seoul
RECRUITING
Samsung Medical Center, Seoul
RECRUITING
Seoul University Hospital, Seoul
RECRUITING
Severance Hospital Yonsei University, Seoul
RECRUITING
START MADRID_Hospital Universitario Fundacion Jimenez Diaz, Madrid
RECRUITING
START MADRID_Hospital Universitario HM Sanchinarro - CIOCC, Madrid
RECRUITING
Instituto de Investigacion Oncologica Vall d'Hebron (VHIO) - EPON, Barcelona
RECRUITING
NEXT Oncology-Hospital Quironsalud Barcelona, Barcelona
NOT_YET_RECRUITING
START Rioja, Rioja
RECRUITING
Hospital Clinico Universitario de Valencia, Valencia
RECRUITING
Sarah Cannon Research Institute UK, London
RECRUITING
Freeman Hospital, Newcastle upon Tyne
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
PMV Pharmaceuticals, Inc
INDUSTRY